Summary
President Trump announced a partnership with Pfizer to offer its drugs at reduced prices through a new government website called TrumpRx.gov. The site aims to match U.S. drug prices more closely to those in other developed countries. The launch is expected in 2026, but details on discount calculations remain unclear.
Key Facts
- President Trump introduced a deal with Pfizer to sell drugs at lower prices to U.S. consumers.
- The discounted drugs will be available on TrumpRx.gov, a government-run website.
- The initiative seeks to align U.S. drug prices with those in other developed nations, a concept known as most-favored-nation pricing.
- Pfizer drugs on the website are projected to be 50% cheaper on average, though specifics on pricing details are not provided.
- The website will target consumers not using health insurance; those with insurance may get better prices elsewhere.
- TrumpRx.gov is expected to launch in 2026 and will direct users to drug companies' direct-order websites.
- The agreement terms remain confidential, and it is not yet clear how the impact on consumer savings will unfold.
- The deal will particularly affect uninsured patients, as insured patients may still pay lower prices with their existing coverage.
